Jon Jones fails UFC 214 drug test

ANAHEIM, CA - JULY 28: Jon Jones prepares to enter the arena during the UFC 214 weigh-in inside the Honda Center on July 28, 2017 in Anaheim, California. (Photo by Jeff Bottari/Zuffa LLC/Zuffa LLC via Getty Images)

On August 22, 2017, the UFC was notified by US Anti-Doping Agency (USADA) of a potential anti-doping violation in regards to UFC Lightweight ChampionJon Jones. This was reportedly stemming from a sample collected following his weigh-in on July 28th, 2017 prior to his UFC 214 fight against Daniel Cormier.

The UFC has released a statement acknowledging the results collected by USADA.

Jon Jones fails UFC 214 drug test

As of right now, the promotion has not officially stripped Jon Jones of his win and belt. The aforementioned Jones has not yet released a statement as of writing this.

As reported by TMZ, Jones tested positive for the steroid Turinabol (4-Chlorodehydromethyltestosterone), a steroid generally used to add lean muscle mass.

By USADA standards, first-time offenders would face a two-year suspension. This would be Jones second positive result from testing. The first offense was prior to UFC 200 in July 2016. Jones was forced to serve a one-year ban. He could potentially be facing a 4-year suspension by USADA this time around.

At 30-years-old, it seemed as though Jon Jones was ready to become an active champion once more after his lengthy list of past issues. Following the UFC 214 title win, he called out current WWE star and former UFC Heavyweight Champion; Brock Lesnar.

Rumor has it, prior to Jones getting popped this time around, the UFC was working on a Jon Jones vs. Stipe Miocic super fight at UFC 218 in Detroit.

Main Photo: ANAHEIM, CA – JULY 28: Jon Jones prepares to enter the arena during the UFC 214 weigh-in inside the Honda Center on July 28, 2017 in Anaheim, California. (Photo by Jeff Bottari/Zuffa LLC/Zuffa LLC via Getty Images)

LEAVE A REPLY

Please enter your comment!
Please enter your name here